Paper Details
- Home
- Paper Details
Original Abstract of the Article :
Rowasa (mesalamine) rectal suspension enema, a new product by Reid-Rowell, represents a major breakthrough in the treatment of distal ulcerative colitis. It provides patients with an alternative therapy to the current oral and enema preparations. This treatment reduces the incidence of unwanted side...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1097/00001610-198901220-00011
データ提供：米国国立医学図書館（NLM）
Rowasa Suspension Enema: A Breakthrough in Ulcerative Colitis Treatment
Ulcerative colitis, an inflammatory bowel disease, can be a debilitating condition. This research introduces Rowasa (mesalamine) rectal suspension enema, a novel treatment option for distal ulcerative colitis. The researchers explore the benefits of this new enema preparation compared to existing oral and enema therapies.
Rowasa: A Targeted Approach to Ulcerative Colitis
The study highlights Rowasa's ability to deliver mesalamine directly to the affected area, minimizing systemic side effects associated with oral therapy. This targeted approach offers a promising alternative for patients with distal ulcerative colitis, potentially improving their quality of life and reducing the burden of unwanted side effects.
Navigating the Desert of Ulcerative Colitis
Imagine a desert landscape, where navigating the terrain can be challenging and unpredictable. Similarly, managing ulcerative colitis can be a difficult journey. This research offers hope for patients with this condition, introducing a new treatment option that aims to provide relief and improve their quality of life.
Dr.Camel's Conclusion
This research introduces Rowasa, a new rectal suspension enema containing mesalamine, as a promising treatment option for distal ulcerative colitis. The targeted delivery of mesalamine offers potential benefits for patients, minimizing systemic side effects and improving quality of life.
Date :
- Date Completed 1991-04-04
- Date Revised 2019-10-29
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.